Scopio Labs announced today its strategic alliance with Siemens Healthineers has expanded to include the global distribution of Scopio's Full-Field Bone Marrow Aspiratetm (FF-BMA) Application*, the ...

A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a ...

A new study reveals a mutation mechanism in osteosarcoma, promising advances in treatment and prognosis for this challenging ...